<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Lymphoid-enhancer-binding factor 1 (LEF1), coupling with β-catenin, functions as a key nuclear mediator of WNT/β-catenin signaling, which regulates cell proliferation and survival </plain></SENT>
<SENT sid="1" pm="."><plain>LEF1 has an important role in lymphopoiesis, and is normally expressed in T and pro-B cells but not mature B cells </plain></SENT>
<SENT sid="2" pm="."><plain>However, gene expression profiling demonstrates overexpression of LEF1 in <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, and knockdown of LEF1 decreases the survival of the leukemic cells </plain></SENT>
<SENT sid="3" pm="."><plain>So far, the data on LEF1 expression in B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are limited </plain></SENT>
<SENT sid="4" pm="."><plain>This study represents the first attempt to assess LEF1 by immunohistochemistry in a large series (290 cases) of B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Strong nuclear staining of LEF1 was observed in virtually <z:hpo ids='HP_0000001'>all</z:hpo> neoplastic cells in 92 of 92 (100%) <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo> including two CD5- cases, with strongest staining in cells with Richter's transformation </plain></SENT>
<SENT sid="6" pm="."><plain>LEF1 also highlighted the morphologically inconspicuous small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> component in three composite <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> 53 mantle cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, 31 low-grade follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 31 marginal zone <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, including 3 CD5+ cases, were negative </plain></SENT>
<SENT sid="8" pm="."><plain>In 12 grade 3 follicular <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, LEF1 was positive in a small subset (5-15%) of cells </plain></SENT>
<SENT sid="9" pm="."><plain>Diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, however, demonstrated significant variability in LEF1 expression with overall positivity in 27 of 71 (38%) cases </plain></SENT>
<SENT sid="10" pm="."><plain>Our results demonstrate that nuclear overexpression of LEF1 is highly associated with <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and may serve as a convenient marker for differential diagnosis of small B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>The expression of β-catenin, the coactivator of LEF1 in WNT signaling, was examined in 50 <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphomas</z:hpo>, of which 44 (88%) showed negative nuclear staining </plain></SENT>
<SENT sid="12" pm="."><plain>The findings of universal nuclear overexpression of LEF1 but lack of nuclear β-catenin in the majority of <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> suggest that the pro-survival function of LEF1 in this disease may be independent of WNT/β-catenin signaling </plain></SENT>
</text></document>